9781605475912-1605475912-Advances in Surgical Pathology: Lung Cancer (Advances in Surgical Pathology Series)

Advances in Surgical Pathology: Lung Cancer (Advances in Surgical Pathology Series)

ISBN-13: 9781605475912
ISBN-10: 1605475912
Edition: 1
Author: Timothy Craig Allen, Mary Beth Beasley, Sanja Dacic, Philip T. Cagle, Keith M. Keer
Publication date: 2010
Publisher: Lippincott Williams & Wilkins
Format: Hardcover 303 pages
FREE US shipping
Buy

From $149.99

Book details

ISBN-13: 9781605475912
ISBN-10: 1605475912
Edition: 1
Author: Timothy Craig Allen, Mary Beth Beasley, Sanja Dacic, Philip T. Cagle, Keith M. Keer
Publication date: 2010
Publisher: Lippincott Williams & Wilkins
Format: Hardcover 303 pages

Summary

Advances in Surgical Pathology: Lung Cancer (Advances in Surgical Pathology Series) (ISBN-13: 9781605475912 and ISBN-10: 1605475912), written by authors Timothy Craig Allen, Mary Beth Beasley, Sanja Dacic, Philip T. Cagle, Keith M. Keer, was published by Lippincott Williams & Wilkins in 2010. With an overall rating of 3.6 stars, it's a notable title among other books. You can easily purchase or rent Advances in Surgical Pathology: Lung Cancer (Advances in Surgical Pathology Series) (Hardcover) from BooksRun, along with many other new and used books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.05.

Description

Advances in Surgical Pathology: Lung Cancer , a volume in the Advances in Surgical Pathology series, features chapters on current and impending changes in the field of lung cancer that directly affect pathologists. This includes the 2004 updates of the WHO Classification of Tumors of the Lung; the ongoing new classification of neuroendocrine carcinomas of the lung by the International Association for the Study of Lung Cancer; the ongoing revision of the pathologic and clinical staging of lung cancer by the AJCC; molecular diagnostics in the diagnosis of lung cancer; the role of the pathologist in the new molecular targeted therapies for lung cancer; and the new use of image-guided, multimodality theranostics for the diagnosis and treatment of lung cancer. Other current topics discussed include new understanding of the premalignant and preinvasive lesions and the controversies and revisions of the diagnosis of bronchioloalveolar carcinoma.
Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book